TY - JOUR
T1 - Sex-specific association between schizophrenia polygenic risk and subclinical schizophrenia-related traits
AU - Mas-Bermejo, Patricia
AU - Papiol, Sergi
AU - Torrecilla, Pilar
AU - Lavín, Valeria
AU - Kwapil, Thomas R.
AU - Barrantes-Vidal, Neus
AU - Rosa, Araceli
N1 - The present work was supported by the Spanish Ministry of Science and Innovation (PID2020-119211RB-I00) and the Generalitat de Catalunya (2021SGR00706 and 2021SGR01010). P. Mas-Bermejo was funded by the PhD scholarship program FI-SDUR (2021-FISDU-00032) from Agencia de Gesti\u00F3n de Ayudas Universitarias y de Investigaci\u00F3n (AGAUR). N Barrantes-Vidal was supported by the ICREA Academia Award of the Generalitat de Catalunya.The genotyping service was carried out at the Genotyping Unit-CEGEN in the Spanish National Cancer Research Centre (CNIO), supported by Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovaci\u00F3n. CEGEN is part of the initiative IMPaCT-GEN\u00F3MICA (IMP/00009) cofunded by ISCIII and the European Regional Development Fund (ERDF).
The present work was supported by the Spanish Ministry of Science and Innovation ( PID2020-119211RB-I00 ) and the Generalitat de Catalunya ( 2021SGR00706 and 2021SGR01010 ). P. Mas-Bermejo was funded by the PhD scholarship program FI-SDUR ( 2021-FISDU-00032 ) from Agencia de Gesti\u00F3n de Ayudas Universitarias y de Investigaci\u00F3n (AGAUR). N Barrantes-Vidal was supported by the ICREA Academia Award of the Generalitat de Catalunya .
The genotyping service was carried out at the Genotyping Unit-CEGEN in the Spanish National Cancer Research Centre (CNIO), supported by Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovaci\u00F3n . CEGEN is part of the initiative IMPaCT-GEN\u00F3MICA (IMP/00009) cofunded by ISCIII and the European Regional Development Fund (ERDF).
PY - 2025/1/10
Y1 - 2025/1/10
N2 - Background: According to the dimensional view of psychiatric disorders, psychosis is expressed as a continuum in the general population. However, the investigation of the putative genetic aetiological continuity between its clinical and subclinical phenotypes has yielded mixed results. We aimed to replicate previous findings regarding the association of polygenic risk for schizophrenia with subclinical traits (i.e., schizotypy traits and psychotic-like experiences), and to examine the role of sex in this association in a large nonclinical sample. Methods: The Multidimensional Schizotypy Scale and the Community Assessment of Psychic Experiences were assessed in 919 nonclinical participants. Polygenic Risk Scores for schizophrenia (SZ-PRSs) were computed using the PRS-CS method based on the latest genome-wide association study of schizophrenia. Summary statistics derived from the total GWAS sample and stratified by sex were used. Linear regression analyses tested the associations of the SZ-PRSs with the psychometric variables, both in the total sample and by sex. Results: No associations were found between the SZ-PRSs and the positive, negative or disorganized dimensions of schizotypy in the total sample. Likewise, no associations were found with psychotic-like experiences. However, the sex-stratified analyses revealed a male-specific association with positive schizotypy. Similar results were obtained with the PRSs derived from the sex-stratified summary statistics. Discussion: Our results are consistent with the lack of clear evidence of an association between SZ common genetic risk and its subclinical phenotypes. Nevertheless, the male-specific association found suggests that this PRS might explain better the male phenotype, as reported in previous studies. Future studies should put a focus on the role of sex in this association to unravel its sex specificities.
AB - Background: According to the dimensional view of psychiatric disorders, psychosis is expressed as a continuum in the general population. However, the investigation of the putative genetic aetiological continuity between its clinical and subclinical phenotypes has yielded mixed results. We aimed to replicate previous findings regarding the association of polygenic risk for schizophrenia with subclinical traits (i.e., schizotypy traits and psychotic-like experiences), and to examine the role of sex in this association in a large nonclinical sample. Methods: The Multidimensional Schizotypy Scale and the Community Assessment of Psychic Experiences were assessed in 919 nonclinical participants. Polygenic Risk Scores for schizophrenia (SZ-PRSs) were computed using the PRS-CS method based on the latest genome-wide association study of schizophrenia. Summary statistics derived from the total GWAS sample and stratified by sex were used. Linear regression analyses tested the associations of the SZ-PRSs with the psychometric variables, both in the total sample and by sex. Results: No associations were found between the SZ-PRSs and the positive, negative or disorganized dimensions of schizotypy in the total sample. Likewise, no associations were found with psychotic-like experiences. However, the sex-stratified analyses revealed a male-specific association with positive schizotypy. Similar results were obtained with the PRSs derived from the sex-stratified summary statistics. Discussion: Our results are consistent with the lack of clear evidence of an association between SZ common genetic risk and its subclinical phenotypes. Nevertheless, the male-specific association found suggests that this PRS might explain better the male phenotype, as reported in previous studies. Future studies should put a focus on the role of sex in this association to unravel its sex specificities.
KW - Genetic overlap
KW - Polygenic risk score
KW - Psychotic-like experiences
KW - Schizophrenia
KW - Schizotypy
KW - Sex differences
UR - http://www.scopus.com/inward/record.url?scp=85205832821&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85205832821&partnerID=8YFLogxK
U2 - 10.1016/j.pnpbp.2024.111161
DO - 10.1016/j.pnpbp.2024.111161
M3 - Article
C2 - 39368539
AN - SCOPUS:85205832821
SN - 0278-5846
VL - 136
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
M1 - 111161
ER -